Keyphrases
Antibiotics
63%
Pediatric
59%
COVID-19
57%
Urinary Tract Infection
55%
Children's Hospital
47%
Virus
46%
Staphylococcus Aureus
45%
Uropathogenic Escherichia Coli
45%
Antimicrobial Stewardship Program
40%
United States
39%
Escherichia Coli
38%
Cytomegalovirus
37%
Methicillin-resistant Staphylococcus Aureus
36%
Antibiotic Use
31%
St. Louis
31%
Soft Tissue Infection
31%
Skin Tissue
30%
Pediatric Patients
29%
Missouri
28%
Antimicrobial Stewardship
27%
Polymerase Chain Reaction
27%
Antimicrobial
27%
Methicillin-resistant S. Aureus
26%
Klebsiella Pneumoniae (K. pneumoniae)
26%
L-plastin
25%
Confidence Interval
25%
Risk Factors
24%
Bladder
23%
Hospitalized children
23%
Infections in children
22%
Respiratory Syncytial Virus
21%
Viral
21%
Stewardship
19%
Neonatal Intensive Care Unit
18%
Lung Transplantation
18%
Pediatric Infectious Disease
17%
Cytomegalovirus Infection
17%
Infection Prevention
17%
Murine Model
16%
Infectious Diseases
16%
Epidemiology
16%
Clinical Outcomes
16%
Neonate
15%
Ehrlichia
15%
Ganciclovir
15%
Autophagy
15%
Recurrent Urinary Tract Infections (rUTIs)
14%
CA-MRSA
14%
Pyelonephritis
14%
Bloodstream Infection
14%
Decolonization
14%
Pediatric Intensive Care Unit
14%
Macrophages
14%
Astrovirus
14%
Renal Transplant Recipients
14%
Influenza
13%
Cystic Fibrosis
13%
Bacterial Infection
13%
Antimicrobial Use
13%
Viremia
13%
Actin-binding Proteins
13%
Antibiotic Resistance
13%
High Risk
12%
Viral Infection
12%
Vaccination
12%
Community-acquired Pneumonia
12%
Quantitative PCR
12%
Blood Culture
12%
Urinary Tract
12%
Antibiotic Duration
12%
Staphylococcal Infections
12%
Herpes Simplex Virus
12%
Plasmodium Falciparum
12%
Leukocytes
12%
Cerebrospinal Fluid
12%
Odds Ratio
11%
Microbiome
11%
Pediatric Lung Transplantation
11%
Intracellular Bacterial Communities
11%
Antibiotic Therapy
11%
Adjusted Odds Ratio
11%
Virome
11%
Cystitis
11%
Pediatric Antimicrobial Stewardship
11%
Kidney
11%
Respiratory Viruses
11%
Multisystem Inflammatory Syndrome in children (MIS-C)
11%
Lipooligosaccharide
11%
Virulence
11%
Hospitalization
11%
Pneumonia
11%
Clostridium Difficile Infection
11%
Intensive Care Unit Patients
10%
APOBEC3A
10%
Fever
10%
Enterovirus
10%
Child Hospitalized
10%
Rational Antibiotic Use
10%
Antibiotic Prescribing
10%
BK Polyomavirus (BKPyV)
10%
Medicine and Dentistry
Pediatrics
100%
Infection
77%
Diseases
44%
Antibiotics
42%
Antiinfective Agent
40%
COVID-19
37%
Cytomegalovirus
32%
Infectious Disease
26%
Severe Acute Respiratory Syndrome Coronavirus 2
24%
Polymerase Chain Reaction
23%
Virus
23%
Urinary Tract Infection
20%
Staphylococcus Aureus
20%
Bloodstream Infection
20%
Antibiotic Therapy
19%
Pathogen
19%
Cytomegalovirus Infection
18%
Lung Transplantation
18%
Pediatrics Patient
17%
Pediatric Infection
17%
Cohort Effect
17%
Methicillin Resistant Staphylococcus Aureus
16%
Intensive Care Unit
16%
Health Care Cost
15%
Odds Ratio
14%
Soft Tissue Infection
14%
Uropathogenic Escherichia Coli
14%
Viremia
14%
Kidney Graft
14%
Clinician
14%
Quality Improvement
13%
Cerebrospinal Fluid
13%
Prevalence
13%
Intensive Care
13%
Ganciclovir
12%
Neonate
12%
Antibiotic Resistance
11%
Encephalitis
11%
Clinical Trial
10%
Virus Infection
10%
Neonatal Intensive Care Unit
10%
Serositis
10%
Microbiome
10%
Community-Acquired Pneumonia
10%
Pyelonephritis
9%
Epstein Barr Virus
9%
Emergency Department
9%
Outpatient
9%
Sepsis
9%
Leukocyte
9%
Human Respiratory Syncytial Virus
9%
Azithromycin
9%
Bladder
9%
Viral Respiratory Tract Infection
9%
Infection Prevention
8%
Vancomycin
8%
Household
8%
Surgical Infection
8%
Virus DNA
8%
Escherichia coli
8%
Enterovirus D68
8%
Cystic Fibrosis
8%
Abscess
7%
Blood Culture
7%
Malignant Neoplasm
7%
Meningitis
7%
Human Immunodeficiency Virus
7%
Ehrlichiosis
7%
Osteomyelitis
7%
Biological Marker
7%
Respiratory Tract Infection
7%
Immunosuppressive Treatment
7%
Bacterial Infection
6%
Cohort Analysis
6%
Telemedicine
6%
Serotype
6%
Placebo
6%
Recurrent Disease
6%
Cystitis
5%
Meticillin
5%
Wheeze
5%
Pseudomonic Acid
5%
Tertiary Care
5%
Diarrhea
5%
Stem Cell Transplant
5%
Central Venous Catheter
5%
Health Care
5%
Immunocompromised Patient
5%
Skin Infection
5%
Sickle-Cell Disease
5%
Autophagy
5%
Bronchiolitis
5%
Influenza Vaccine
5%
Case-Control Study
5%
Amoxicillin
5%
Adverse Event
5%
Trimethoprim/Sulfamethoxazole
5%
RNA 16S
5%
Metronidazole
5%
Cancer
5%
Immunology and Microbiology
Urinary Tract
64%
Virus
52%
Uropathogenic Escherichia Coli
49%
Infectious Agent
49%
Staphylococcus Aureus
47%
Escherichia coli
40%
Cytomegalovirus
35%
Methicillin-Resistant Staphylococcus Aureus
26%
Klebsiella pneumoniae
24%
Viremia
22%
Microbiome
20%
Metagenomics
20%
Macrophage
20%
Autophagy
19%
Prevalence
19%
Lung Transplantation
19%
Actin
18%
T Cell
18%
Polymerase Chain Reaction
18%
Human Respiratory Syncytial Virus
17%
Pilus
17%
Astroviridae
16%
Viral Disease
15%
Leukocyte
14%
Soft Tissue
14%
Antimicrobial Resistance
14%
Titer
14%
Neutrophil
13%
Neisseria meningitidis
13%
Antibody Response
12%
Gut Microbiome
11%
Microflora
11%
B Cell
11%
Epstein Barr Virus
11%
Mouse Model
11%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
BK Virus
10%
Human Immunodeficiency Virus
10%
Immune Response
10%
Serotype
10%
Cytokine
10%
Taxon
9%
Airway
9%
Herpes Simplex Virus
9%
Biofilm
9%
Dynamics
9%
Monoclonal Antibody
9%
Human Microbiome
9%
Blood Plasma
9%
DNA Virus
8%
Cytomegalovirus Infection
8%
Maturation
8%
Respiratory Virus
8%
Outer Membrane
8%
Ehrlichia
8%
interferon
8%
Polyomavirus
8%
Gene Expression
8%
Enterovirus
7%
Microorganism
7%
Influenza
7%
Gardnerella vaginalis
7%
Immunoglobulin G
7%
Epitope
7%
Intestine Flora
7%
Plasmodium falciparum
7%
Encephalitis
6%
Ehrlichia ewingii
6%
Normal Human
6%
Pyelonephritis
6%
Cerebrospinal Fluid
6%
Viral Load
6%
Whole Genome Sequencing
6%
Methicillin Susceptible Staphylococcus Aureus
6%
Cryptococcus neoformans
6%
Cell Migration
6%
Wild Type
6%
Central Nervous System
6%
Tacrolimus
6%
Human Astrovirus
6%
Seropositivity
6%
Immunosuppression
6%
Pneumonitis
6%
Intravenous Immunoglobulin
6%
Human Virome
6%
Anelloviridae
6%
Innate Immune System
6%
Bronchiolitis
6%
Molecular Epidemiology
6%
Kawasaki Disease
5%
Gene Sequence
5%
Streptococcus Agalactiae
5%
Vaginitis
5%
Plasmodium
5%
Serology
5%
Resistome
5%
Virulence Factor
5%
Genetic Variability
5%
Probiotic
5%
Lineages
5%